Retaglutide is a novel GLP-1 receptor agonist currently under research for the management of metabolic disorders. This therapy works by mimicking the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring https://alyshaubcv679072.aboutyoublog.com/47852940/semaglutide-a-potential-solution-for-obesity